losartan has been researched along with kainic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atanasova, M; Ilieva, K; Ivanova, N; Pechlivanova, D; Tchekalarova, J | 1 |
| Atanasova, D; Ivanova, NM; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD | 1 |
| Atanasova, D; Atanassova, N; Ivanova, N; Lazarov, N; Nenchovska, Z; Pavlova, E; Tchekalarova, J | 1 |
3 other study(ies) available for losartan and kainic acid
| Article | Year |
|---|---|
Strain-dependent effects of sub-chronically infused losartan against kainic acid-induced seizures, oxidative stress, and heat shock protein 72 expression.
Topics: Animals; Cerebral Cortex; Cytosol; Hippocampus; HSP72 Heat-Shock Proteins; Infusions, Subcutaneous; Kainic Acid; Lipid Peroxidation; Losartan; Male; Mitochondria; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Seizures; Superoxide Dismutase | 2014 |
Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Epilepsy, Temporal Lobe; Kainic Acid; Losartan; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2014 |
Losartan suppresses the kainate-induced changes of angiotensin AT
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Blood Pressure; Comorbidity; Disease Models, Animal; Epilepsy; Gene Expression; Hippocampus; Hypertension; Kainic Acid; Limbic System; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2018 |